Good Pasture Syndrome clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Imlifidase in Anti-GBM Disease
Sorry, in progress, not accepting new patients
An open-label, controlled, randomised, multi-centre Phase 3 trial evaluating renal function in patients with severe anti-GBM disease comparing imlifidase and standard of care (SoC) with SoC alone. All patients will remain in the trial for 24 months.
at UCLA
Our lead scientists for Good Pasture Syndrome research studies include Suphamai Bunnapradist, MD, MS.
Last updated: